1. Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi. Issue 1 (January 2017) Authors: Visco, Carlo; Chiappella, Annalisa; Nassi, Luca; Patti, Caterina; Ferrero, Simone; Barbero, Daniela; Evangelista, Andrea; Spina, Michele; Molinari, Annalia; Rigacci, Luigi; Tani, Monica; Rocco, Alice Di; Pinotti, Graziella; Fabbri, Alberto; Zambello, Renato; Finotto, Silvia; Gotti, Manuel; Carell... Journal: Lancet Issue: Volume 4:Issue 1(2017) Page Start: e15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial. Issue 11 (November 2017) Authors: Ferreri, Andrés J M; Cwynarski, Kate; Pulczynski, Elisa; Fox, Christopher P; Schorb, Elisabeth; La Rosée, Paul; Binder, Mascha; Fabbri, Alberto; Torri, Valter; Minacapelli, Eleonora; Falautano, Monica; Ilariucci, Fiorella; Ambrosetti, Achille; Roth, Alexander; Hemmaway, Claire; Johnson, Peter; Li... Journal: Lancet Issue: Volume 4:Issue 11(2017) Page Start: e510 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Radiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma. Issue 10 (3rd October 2015) Authors: Cencini, Emanuele; Fabbri, Alberto; Schiattone, Luana; Bartalucci, Giulia; Bocchia, Monica Journal: Leukemia & lymphoma Issue: Volume 56:Issue 10(2015:Oct.) Page Start: 2997 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The significance of serum immunoglobulin paraprotein in diffuse large B‐cell lymphoma. (17th August 2017) Authors: Cox, M. Christina; Di Napoli, Arianna; Fabbri, Alberto; Cencini, Emanuele; Ruco, Luigi Journal: British journal of haematology Issue: Volume 182:Number 5(2018) Page Start: 741 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non‐hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab. (11th September 2018) Authors: Cencini, Emanuele; Sicuranza, Anna; Fabbri, Alberto; Ferrigno, Ilaria; Rigacci, Luigi; Cox, Maria C.; Raspadori, Donatella; Bocchia, Monica Journal: British journal of haematology Issue: Volume 184:Number 2(2019) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pixantrone in patients with relapsed/refractory diffuse large B‐cell lymphoma: A real‐life, retrospective, multicenter trial on behalf of the "RTL" (Regional Tuscan Lymphoma network). (30th January 2022) Authors: Cencini, Emanuele; Mecacci, Bianca; Rocco, Melania; Innocenti, Fabio; Ghio, Francesco; Puccini, Benedetta; Della Seta, Roberta; Simonetti, Federico; Mannelli, Lara; Cuccaro, Annarosa; Bocchia, Monica; Fabbri, Alberto Journal: European journal of haematology Issue: Volume 108:Number 5(2022) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long‐term remission in a case of plasmablastic lymphoma treated with COMP (cyclophosphamide, liposomal doxorubicin, vincristine, prednisone) and bortezomib. (19th January 2016) Authors: Cencini, Emanuele; Fabbri, Alberto; Guerrini, Susanna; Mazzei, Maria Antonietta; Rossi, Vania; Bocchia, Monica Journal: European journal of haematology Issue: Volume 96:Number 6(2016:Jun.) Page Start: 650 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long‐lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B‐cell lymphoma who are not eligible for or failed autologous transplantation. Issue 3 (5th May 2020) Authors: Ferreri, Andrés J. M.; Sassone, Marianna; Angelillo, Piera; Zaja, Francesco; Re, Alessandro; Di Rocco, Alice; Spina, Michele; Fabbri, Alberto; Stelitano, Caterina; Frezzato, Maurizio; Volpetti, Stefano; Zambello, Renato; Rusconi, Chiara; De Lorenzo, Daniela; Scarano, Eloise; Arcari, Annalisa; Ber... Journal: Hematological oncology Issue: Volume 38:Issue 3(2020) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B‐cell lymphoma of the central nervous system – an international study of feasibility and efficacy in routine clinical practice. (29th January 2020) Authors: Schorb, Elisabeth; Fox, Christopher P.; Kasenda, Benjamin; Linton, Kim; Martinez‐Calle, Nicolas; Calimeri, Teresa; Ninkovic, Slavisa; Eyre, Toby A.; Cummin, Tom; Smith, Jeffery; Yallop, Deborah; De Marco, Beatrice; Krampera, Mauro; Trefz, Stefan; Orsucci, Lorella; Fabbri, Alberto; Illerhaus, Gera... Journal: British journal of haematology Issue: Volume 189:Number 5(2020) Page Start: 879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy. Issue 12 (11th December 2022) Authors: Argnani, Lisa; Broccoli, Alessandro; Pellegrini, Cinzia; Fabbri, Alberto; Puccini, Benedetta; Bruna, Riccardo; Tisi, Maria Chiara; Masia, Francesco; Flenghi, Leonardo; Nizzoli, Maria Elena; Musso, Maurizio; Salerno, Marilena; Scalzulli, Potito Rosario; Dessi', Daniela; Ferrarini, Isacco; Pennese,... Journal: HemaSphere Issue: Volume 6:Issue 12(2022) Page Start: e798 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗